SINONASAL SQUAMOUS CELL CARCINOMA
Clinical trials for SINONASAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SINONASAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SINONASAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo may spare head & neck cancer patients from major surgery
Disease control Recruiting nowThis study tests giving chemotherapy and an immunotherapy drug before standard surgery for head and neck cancer. The goal is to shrink the tumor enough so that doctors can do a smaller, function-saving surgery, reducing side effects like trouble swallowing, speaking, or seeing. A…
Matched conditions: SINONASAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 13:44 UTC
-
New combo therapy aims to shrink hard-to-treat sinus cancers before surgery
Disease control Recruiting nowThis study is for people with a type of sinus cancer called sinonasal squamous cell carcinoma. It compares standard chemotherapy alone to chemotherapy plus an immunotherapy drug (cemiplimab) given before surgery. The goal is to see if adding immunotherapy helps shrink tumors more…
Matched conditions: SINONASAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:09 UTC